Loading company…
ProFactor Pharma develops and manufactures low-cost recombinant factor VIII products for patients with Haemophilia A.
Founded in 2009 in Midlothian, UK, ProFactor Pharma Ltd. (PFP) develops and manufactures low-cost recombinant factor VIII products for Haemophilia A. Its founders are Bruce Vernon and Richard Cruse. In June 2020 PFP raised GBP 1 million in a round led by Kelvin Capital, with participation from Ingenza Ltd. and Scottish Enterprise, at a post-money valuation of GBP 6.41 million. The company reported revenue of GBP 1,091,000 in its most recent year.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in